ACLS Overview

Axcelis Technologies, Inc. is primarily a producer of ion implantation equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the enabling steps in the IC manufacturing process. The Company's products include High Current, Medium Energy, High Energy, Mid Current, and GSD Ovation. The Company's Purion H6 next generation high current ion implanters deliver process control by leveraging its spot beam architecture, optimized for the full spectrum of high-current applications. The Company's Purion H200 is its state-of-the-art single wafer high current medium energy implanter. Its Purion XE Series high energy ion implanters use RF Linear Accelerator (LINAC) technology. The Company's Purion M ion implanters offer the broadest spectrum of mid-current doses available.

Wall Street analysts forecast ACLS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACLS is99.67 USD with a low forecast of 94.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Axcelis Technologies Inc revenue for the last quarter amounts to 198.96M USD, increased 3.32

Axcelis Technologies Inc. EPS for the last quarter amounts to 0.30 USD, decreased -65.91

Axcelis Technologies Inc (ACLS) has 1465 emplpoyees as of June 21 2026.

Today ACLS has the market capitalization of 5.76B USD.